Brief: Procept Biorobotics Q3 Adjusted EBITDA USD -12.43 Million Vs. IBES Estimate USD -17.5 Million
28/10/2024 11:00
Oct 28 (Reuters) - Procept Biorobotics Q3 operating income USD -22.427 million vs. IBES estimate USD -27 million. * Q3 net income USD -20.974 million vs. IBES estimate USD -25.4 million * Q3 basic EPS USD -0.4 * Q3 gross profit USD 36.911 million * Q3 revenue USD 58.37 million vs. IBES estimate USD 53.2 million * outlook FY revenue USD 222.5-223 million * outlook FY gross margin 61%
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc